BR112021016747A2 - Método para tratamento de um meloma múltiplo - Google Patents

Método para tratamento de um meloma múltiplo Download PDF

Info

Publication number
BR112021016747A2
BR112021016747A2 BR112021016747-1A BR112021016747A BR112021016747A2 BR 112021016747 A2 BR112021016747 A2 BR 112021016747A2 BR 112021016747 A BR112021016747 A BR 112021016747A BR 112021016747 A2 BR112021016747 A2 BR 112021016747A2
Authority
BR
Brazil
Prior art keywords
compound
multiple myeloma
subject
pharmaceutical composition
individual
Prior art date
Application number
BR112021016747-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Marla L. Weetall
Liangxian Cao
Arnold Bolomsky
Heinz Ludwig
Original Assignee
Ptc Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ptc Therapeutics, Inc. filed Critical Ptc Therapeutics, Inc.
Publication of BR112021016747A2 publication Critical patent/BR112021016747A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112021016747-1A 2019-02-28 2020-02-26 Método para tratamento de um meloma múltiplo BR112021016747A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962812002P 2019-02-28 2019-02-28
US62/812,002 2019-02-28
PCT/US2020/019884 WO2020176610A1 (en) 2019-02-28 2020-02-26 Method for treating a multiple myeloma

Publications (1)

Publication Number Publication Date
BR112021016747A2 true BR112021016747A2 (pt) 2021-10-19

Family

ID=72238680

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021016747-1A BR112021016747A2 (pt) 2019-02-28 2020-02-26 Método para tratamento de um meloma múltiplo

Country Status (11)

Country Link
US (1) US20220143016A1 (cg-RX-API-DMAC7.html)
EP (1) EP3931196A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022521801A (cg-RX-API-DMAC7.html)
CN (1) CN113710670A (cg-RX-API-DMAC7.html)
AU (1) AU2020227748A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021016747A2 (cg-RX-API-DMAC7.html)
CA (1) CA3131249A1 (cg-RX-API-DMAC7.html)
EA (1) EA202192117A1 (cg-RX-API-DMAC7.html)
IL (1) IL285800A (cg-RX-API-DMAC7.html)
MX (1) MX2021010398A (cg-RX-API-DMAC7.html)
WO (1) WO2020176610A1 (cg-RX-API-DMAC7.html)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH593266A5 (cg-RX-API-DMAC7.html) * 1973-09-20 1977-11-30 Delalande Sa
EP1351691A4 (en) * 2000-12-12 2005-06-22 Cytovia Inc SUBSTITUTED 2-ARYL-4-ARYLAMINOPYRIMIDINES AND ANALOGUES AS ACTIVATORS OF CASPASES AND APOPTOSIS INDUCERS, AND USE THEREOF
EP2624818B1 (en) * 2010-10-05 2017-04-05 Fresenius Kabi USA, LLC Bortezomib formulations stabilised with boric acid
PH12015501130B1 (en) * 2012-11-21 2023-01-27 Ptc Therapeutics Inc Substituted reverse pyrimidine bmi-1 inhibitors
MX370588B (es) * 2013-08-30 2019-12-16 Ptc Therapeutics Inc Inhibidores de la bmi-1 de pirimidina sustituida.
JP2021535198A (ja) * 2018-08-17 2021-12-16 ピーティーシー セラピューティクス, インコーポレイテッド 膵臓癌を治療する方法
KR20210151061A (ko) * 2019-03-11 2021-12-13 피티씨 테라퓨틱스, 인크. 향상된 생체이용률을 갖는 화합물 형태 및 이의 제형

Also Published As

Publication number Publication date
US20220143016A1 (en) 2022-05-12
WO2020176610A1 (en) 2020-09-03
EP3931196A4 (en) 2022-12-14
AU2020227748A1 (en) 2021-09-16
MX2021010398A (es) 2022-01-18
CN113710670A (zh) 2021-11-26
EA202192117A1 (ru) 2021-11-23
CA3131249A1 (en) 2020-09-03
EP3931196A1 (en) 2022-01-05
JP2022521801A (ja) 2022-04-12
WO2020176610A8 (en) 2021-08-12
IL285800A (en) 2021-10-31

Similar Documents

Publication Publication Date Title
US20210353596A1 (en) Combination treatment of cancer
US11458126B2 (en) DHODH inhibitor for use in treating hematologic cancers
TWI688387B (zh) 二氫槲皮素或其醫藥上可接受之鹽、或含有彼之組合物的醫藥用途
KR20170078811A (ko) 원발성 호르몬 저항성 자궁내막암 및 유방암 치료 방법
JP2025032069A (ja) 膵臓癌を治療する方法
CN108472376A (zh) 用于治疗癌症的合理组合疗法
AU2020209767B2 (en) Method for treating an acute myeloid leukemia
US20220143016A1 (en) Method for treating a multiple myeloma
RU2812782C2 (ru) Способ лечения острого миелоидного лейкоза
CN114096537B (zh) 肉瘤治疗方法的有用组合
EA047152B1 (ru) Способ лечения множественной миеломы
EA046841B1 (ru) Комбинации, пригодные в способе лечения саркомы

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07D 471/04 , C07D 403/04 , C07D 487/04

Ipc: C07D 471/04 (2006.01), C07D 403/04 (2006.01), C07D

B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements